Smartwatches Revolutionize Blood Sugar Management: Dexcom G7 and FreeStyle Libre Enhance Apple Watch Integration, Expanding AI-Driven Ecosystem

July 5, 2026

TechRepublic USA

Overview

Smartwatches hold the potential to transform glucose tracking, but current advancements rely on the integration of continuous glucose monitoring (CGM), artificial intelligence (AI), and regulated healthcare technologies. While mainstream smartwatches cannot independently measure blood sugar without external sensors, Dexcom’s G7 now supports direct Apple Watch connection, and Abbott’s FreeStyle Libre platform is expanding smartwatch support. This growing ecosystem of medical-grade sensors, smartphones, and smartwatches significantly enhances self-management for individuals with diabetes.

In Depth

Key Findings

Smartwatches are poised to revolutionize blood sugar tracking and management, though current technological advancements are largely dependent on tight integration with Continuous Glucose Monitoring (CGM) devices, Artificial Intelligence (AI), and rigorously regulated healthcare technologies. As of now, mainstream smartwatches on the market lack the capability to independently and non-invasively measure blood sugar without external, dedicated sensors. However, Dexcom’s G7 has enhanced convenience by supporting direct connection with Apple Watch, and Abbott’s FreeStyle Libre platform is also expanding its smartwatch compatibility. This synergistic development is rapidly fostering an ecosystem where medical-grade sensors, smartphones, and smartwatches collaboratively deliver more personalized and efficient diabetes management.

Technical / Clinical Details

While current smartwatches can measure basic biometric data such as heart rate, activity levels, and sleep patterns, they require dedicated CGM sensors for blood glucose measurement. CGM sensors (e.g., Dexcom G7, FreeStyle Libre 3 Plus) are worn on the skin and continuously measure glucose concentrations in the interstitial fluid. This data is transmitted in real-time to a smartphone via wireless technologies like Bluetooth. Smartwatches then retrieve this glucose data from the smartphone app, enabling direct display on the wrist. This allows patients to check their glucose levels, understand trends, and monitor patterns anytime without needing to retrieve their smartphone. The direct connection between Dexcom G7 and Apple Watch further streamlines this process, allowing data to flow directly from the sensor to the Apple Watch without smartphone intermediation, offering enhanced convenience and faster information delivery. AI can combine CGM data with other biometric data collected by smartwatches (e.g., activity levels, sleep duration) to perform deeper analysis of glucose fluctuations, predict individual glucose responses to lifestyle and diet, and provide personalized health advice.

Background & Context

Individuals with diabetes invest significant time and effort in daily glucose management, constantly needing to be aware of the risks of hypoglycemia and hyperglycemia. The integration of smartwatches and CGMs significantly alleviates this burden and substantially improves patients’ quality of life. While research into non-invasive blood glucose measurement technologies is active, it is believed that achieving medical-grade accuracy and reliability will take more time. Therefore, the current trend focuses on linking highly accurate CGM sensors with smartwatches that excel in data display, analysis, and notification features. This collaboration elevates patient engagement and promotes more proactive self-management, shifting the paradigm of diabetes care. Technology giants like Apple and Google are also intensifying their involvement in the healthcare sector, and their platforms are likely to accelerate such integrations further.

Strategic Significance & Outlook

The integration of smartwatches with blood glucose monitoring is expected to continue its evolution. In the future, advanced non-invasive glucose sensors may be directly embedded into smartwatches themselves, creating an even more seamless user experience. Furthermore, advancements in AI could enable the integration of glucose data with other biomarkers (e.g., ketone bodies, lactate, cortisol) to provide a comprehensive analysis of an individual’s overall metabolic profile. This would empower not only diabetes patients but also healthy individuals to gain detailed insights into their metabolic status, which can be utilized for preventive healthcare and performance optimization. This technological innovation is expected to transform personal health management into a smarter, more integrated system, significantly contributing to the extension of healthy lifespans.

Source: https://www.techrepublic.com/article/news-smartwatch-blood-sugar-revolution-explained/

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.